本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Psyence Biomedical Ltd

5.82
-0.2500-4.12%
盤後5.820.00000.00%19:53 EDT
成交量:4.05萬
成交額:23.99萬
市值:2,219.92萬
市盈率:-0.46
高:6.06
開:6.03
低:5.80
收:6.07
52周最高:34.63
52周最低:1.92
股本:381.43萬
流通股本:109.46萬
量比:0.39
換手率:3.70%
股息:- -
股息率:- -
每股收益(TTM):-12.5596
每股收益(LYR):-12.5596
淨資產收益率:-58.62%
總資產收益率:-31.33%
市淨率:1.31
市盈率(LYR):-0.46

資料載入中...

2024/11/07

SEC問詢函

Form CORRESP - Correspondence
2024/10/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/10/08

SEC問詢函

Form CORRESP - Correspondence
2024/10/02

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/27

SEC問詢函

Form CORRESP - Correspondence
2024/08/20

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC問詢函

Form CORRESP - Correspondence
2024/05/10

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/09

SEC問詢函

Form CORRESP - Correspondence
2024/05/07

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

SEC問詢函

Form CORRESP - Correspondence
2024/04/18

SEC問詢函

Form CORRESP - Correspondence
2024/04/18

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/02/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/23

企業合併公告

Form 425 - Prospectuses and communications, business combinations